Medicare Enrolled
Dr. Hardeep Singh, M.D.
Gastroenterology · Orange, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Singh from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Singh?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Singh
Dr. Hardeep Singh is a gastroenterology specialist in Orange, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Singh performed 3,535 Medicare services across 1,932 unique beneficiaries.
Between the years covered by Open Payments, Dr. Singh received a total of $12,461 from 56 pharmaceutical and/or device companies across 652 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in gastroenterology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Singh is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 3% volume in CA
$12,461 industry payments
Medicare Practice Summary
Medicare Utilization ↗3,535
Medicare services
Top 3% in CA for gastroenterology
1,932
Unique beneficiaries
$85
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~186 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Chronic care management, additional 20 min/month This service covers an extra 20 minutes of clinical staff time directed by a healthcare professional for managing two or more chronic conditions each calendar month. |
930 | $41 | $240 |
| Chronic care management, first 20 min/month This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions. |
549 | $52 | $300 |
| Upper GI endoscopy with biopsy A procedure to collect tissue samples from the esophagus, stomach, or upper small intestine using a flexible tube with a camera. The samples are examined to check for abnormalities. |
338 | $78 | $601 |
| Colon polyp removal with endoscopic snare This procedure removes polyps or growths from the large bowel using a flexible tube with a camera and a wire loop tool. The snare is used to cut off the growths during the examination. |
233 | $200 | $1,089 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
214 | $76 | $440 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
142 | $66 | $360 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
126 | $106 | $600 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
96 | $46 | $278 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
91 | $109 | $580 |
| Remote patient monitoring device, 30 days Initial setup of devices for remote monitoring of body functions with daily data transmission or alerts. This service covers the first 30 days of the monitoring period. |
85 | $45 | $280 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
84 | $124 | $780 |
| Remote patient monitoring management, 20 min/month Management based on results from remote vital sign monitoring for the first 20 minutes per calendar month. |
74 | $41 | $240 |
| Colonoscopy for colorectal cancer screening, high risk A colonoscopy performed to screen for colorectal cancer in individuals identified as being at high risk for the disease. |
71 | $175 | $795 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
68 | $88 | $540 |
| New patient office visit, 15-29 minutes An initial office visit for a new patient lasting 15 to 29 minutes. This code is used when the total time spent on the date of the encounter meets this duration threshold. |
67 | $46 | $360 |
| Colonoscopy with biopsy A procedure to collect tissue samples from the large intestine using a flexible tube with a camera. The samples are examined to check for abnormalities or disease. |
59 | $74 | $842 |
| Colonoscopy for colorectal cancer screening A colonoscopy performed to screen for colorectal cancer in individuals who are not at high risk for the disease. |
52 | $183 | $782 |
| Endoscopy of digestive tract Imaging of the digestive tract performed from the inside using an endoscope. |
44 | $671 | $3,980 |
| Liver stiffness measurement A non-invasive test that uses ultrasound or similar technology to measure the stiffness of liver tissue. This measurement helps assess the degree of liver fibrosis or scarring. |
40 | $27 | $160 |
| Endoscopic ultrasound-guided needle biopsy A procedure using an ultrasound-equipped endoscope to guide a needle for tissue sampling of the esophagus, stomach, or upper small bowel. |
39 | $205 | $1,125 |
| Endoscopic removal of esophagus, stomach, or small bowel polyps This procedure uses an endoscope and a mechanical snare to remove polyps or growths from the esophagus, stomach, or upper small bowel. |
28 | $146 | $811 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
25 | $145 | $743 |
| Upper endoscopy (EGD) A diagnostic exam of the esophagus, stomach, and upper small bowel using a flexible endoscope. |
20 | $92 | $560 |
| Endoscopic ultrasound of esophagus, stomach, or upper small bowel An ultrasound exam of the esophagus, stomach, and/or upper small bowel performed using a flexible endoscope. |
18 | $176 | $974 |
| Colonoscopy A diagnostic exam of the large bowel using a flexible endoscope to visualize the interior of the colon. |
17 | $136 | $774 |
| Remote physiologic monitoring setup and education Initial setup of remote monitoring equipment and patient education on its use. |
13 | $18 | $120 |
| Moderate sedation during GI endoscopy Sedation services provided by the physician performing a gastrointestinal endoscopic procedure. This requires an independent trained observer to assist in monitoring the patient. |
12 | $4 | $40 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$12,461
Total received (2018-2024)
Avg $1,780/year across 7 years
Top 16% in CA for gastroenterology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
56
Companies
652
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$12,439 (99.8%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$22 (0.2%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,524
2023
$2,229
2022
$2,167
2021
$1,795
2020
$1,188
2019
$1,414
2018
$1,142
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$868
PFIZER INC.
$185
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$170
STERIS CORPORATION
$169
Boston Scientific Corporation
$164
Janssen Biotech, Inc.
$139
QOL Medical, LLC
$137
Takeda Pharmaceuticals U.S.A., Inc.
$123
Celgene Corporation
$119
Ardelyx, Inc.
$88
GENZYME CORPORATION
$49
Ferring Pharmaceuticals Inc.
$39
IRONWOOD PHARMACEUTICALS, INC
$37
AIMMUNE THERAPEUTICS, INC.
$36
VIVUS LLC
$35
Phathom Pharmaceuticals, Inc.
$32
Exact Sciences Corporation
$24
Lilly USA, LLC
$24
ABIOMED
$23
Braintree Laboratories, Inc.
$22
Celltrion USA Inc.
$21
Boehringer Ingelheim Pharmaceuticals, Inc.
$20
Top 3 companies account for 48.4% of 2024 payments
All-time payments by company (2018-2024) ›
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$1,731
AbbVie Inc.
$1,597
ABBVIE INC.
$1,487
Takeda Pharmaceuticals U.S.A., Inc.
$1,057
Celgene Corporation
$808
Boston Scientific Corporation
$698
Janssen Biotech, Inc.
$555
PFIZER INC.
$476
AbbVie, Inc.
$390
QOL Medical, LLC
$245
Gilead Sciences, Inc.
$244
Intercept Pharmaceuticals, Inc.
$234
Ferring Pharmaceuticals Inc.
$199
Allergan Inc.
$178
ERBE USA Inc
$178
STERIS CORPORATION
$169
Merck Sharp & Dohme Corporation
$153
Nestle HealthCare Nutrition Inc.
$138
Prometheus Laboratories Inc.
$136
Ironwood Pharmaceuticals, Inc
$129
RedHill Biopharma Inc.
$120
Ardelyx, Inc.
$107
BOSTON SCIENTIFIC CORPORATION
$100
GENZYME CORPORATION
$96
Braintree Laboratories, Inc.
$95
Amgen Inc.
$90
AstraZeneca Pharmaceuticals LP
$88
CONMED Corporation
$83
Shionogi Inc
$81
UCB, Inc.
$80
Shire North American Group Inc
$63
Regeneron Healthcare Solutions, Inc.
$55
Alfasigma USA, Inc.
$51
Phathom Pharmaceuticals, Inc.
$45
Daiichi Sankyo Inc.
$43
IRONWOOD PHARMACEUTICALS, INC
$37
AIMMUNE THERAPEUTICS, INC.
$36
VIVUS LLC
$35
Fresenius Kabi USA, LLC
$30
INTRA-SANA LABORATORIES
$26
Sandoz Inc.
$26
Exact Sciences Corporation
$24
Lilly USA, LLC
$24
ABIOMED
$23
AMAG Pharmaceuticals, Inc.
$22
Celltrion USA Inc.
$21
Shield Therapeutics Inc
$20
Boehringer Ingelheim Pharmaceuticals, Inc.
$20
CapsoVision, Inc.
$19
Allergan, Inc.
$19
Dova Pharmaceuticals
$18
NESTLE HEALTHCARE NUTRITION INC.
$17
Evoke Pharma, Inc.
$16
Pinnacle Biologics, Inc
$12
Dynavax Technologies Corporation
$10
Ambu Inc.
$6
Top 3 companies account for 38.6% of all-time payments
Associated products mentioned in payments ›
ACCRUFER · ACQUIRE · APRISO · AVSOLA · AXIOS · Amitiza · CIMZIA · CLENPIQ · CREON · CYLTEZO · CapsoCam Plus · Cimzia · Cologuard Collection Kit · DIFICID · DUPIXENT · Doptelet · ENTYVIO · EOHILIA · EXALT · EXALT Model D · Entyvio · FARXIGA · FERAHEME · GATTEX · GENERAL POLYPECTOMY · GENERAL - THERAPIES · GIMOTI · HUMIRA · HYRIMOZ · Heplisav-B · Humira · IBSRELA · INJECTAFER · Impella · LINZESS · Linzess · MAVYRET · MOTEGRITY · MOTOFEN · Motegrity · Movantik · Mulpleta · OCALIVA · OMVOH · Photofrin · QSYMIA · REBYOTA · RELTONE 200 MG · REMICADE · RINVOQ · SKYRIZI · STELARA · SUCRAID · SUFLAVE · SUTAB · Sucraid · Symproic · TREMFYA · TRULANCE · Talicia · UCERIS · VIBERZI · VOQUEZNA · VOWST · VRAYLAR · X-Tack Endoscopic HeliX Tacking System · XELJANZ · XIFAXAN · ZENPEP · ZEPOSIA · ZYMFENTRA · Zelnorm · truFreeze
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Gastroenterologists within 10 mi
290
Per 100K population
9.2
County median income
$113,702
Nearest hospital
PROVIDENCE ST. JOSEPH HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Singh is a clinical cardiology specialist, with above-average Medicare volume (top 3% in CA), with low-engagement industry engagement in the top 16% of CA peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Singh experienced with chronic care management, additional 20 min/month?
Based on Medicare claims data, Dr. Singh performed 930 chronic care management, additional 20 min/month services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Singh receive payments from pharmaceutical companies?
Yes. Dr. Singh received a total of $12,461 from 56 companies across 652 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Singh's costs compare to other gastroenterologists in Orange?
Dr. Singh's average Medicare payment per service is $85. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Singh) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Gastroenterology
Common procedures, typical costs, and what industry payments mean in gastroenterology.
Same specialty & city
Gastroenterologists in Orange
Browse gastroenterologists in Orange ranked by procedure volume and transparency data.
Highest volume
Top Gastroenterologists in CA
Gastroenterologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Gastroenterologists in CA
Which CA gastroenterologists receive the most from drug and device companies.
By company
Salix Pharmaceuticals, a division of Bausch Health US, LLC Payments to Doctors
See all physicians who received payments from Salix Pharmaceuticals, a division of Bausch Health US, LLC.
By company
AbbVie Inc. Payments to Doctors
See all physicians who received payments from AbbVie Inc.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology